News
Contact Us
Support

Home
Our Philosophy
OVITEX
Investors

Press Releases
Events & Presentations

News Releases

News Releases

Year

Sep 13, 2021

TELA Bio® Announces New Data on Use of OviTex in a Range of Hernia Repair Applications, Including Novel ReBAR (Reinforced Biologic Augmented Repair) Technique

Aug 16, 2021

TELA Bio's OviTex® Reinforced Tissue Matrix to be Featured in Three Presentations at SAGES 2021

Aug 11, 2021

TELA Bio Reports Record Second Quarter 2021 Revenues Driven by Increased Demand

Aug 03, 2021

TELA Bio to Participate in Canaccord Genuity’s 41st Annual Growth Conference

Jul 28, 2021

TELA Bio to Announce Second Quarter 2021 Financial Results

Jul 21, 2021

NHS Surgeon First in Europe to Implant TELA Bio's OviTex® LPR Reinforced Tissue Matrix

Jun 14, 2021

TELA Bio to Participate in Upcoming JMP Securities Life Sciences Conference

Jun 02, 2021

TELA Bio Announces Changes to its Board of Directors

May 25, 2021

TELA Bio Names Marissa Conrad as Vice President of Clinical and Regulatory Affairs

May 21, 2021

TELA Bio to Participate in Upcoming Investor Conferences

Pagination

Current page 1
Page 2
Next page
Last page

Print Page

RSS Feeds

Email Alerts

Contact IR

Privacy Policy
Legal
Contact Us

Linkedin
Facebook
Twitter
Instagram

©2021 TELA Bio, Inc. All Rights reserved.